Opus Genetics | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Feb 7 11:45 ET

Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Zaremba Rabourn Amy

Feb 6 16:40 ET

Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Hoffmann Bernhard

Feb 6 16:40 ET

Opus Genetics | 8-K: Current report

Jan 24 16:38 ET

Opus Genetics | 8-K: Current report

Jan 23 17:22 ET

Opus Genetics | 8-K: Current report

Jan 14 09:12 ET

Opus Genetics | 424B5: Prospectus

Jan 13 17:33 ET

Opus Genetics | 8-K/A: Current report (Amendment)

Jan 7 17:14 ET

Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Director MANUSO JAMES S J

Jan 6 16:48 ET

Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Director Bennett Jean

Jan 6 16:45 ET

Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Magrath George

Dec 30, 2024 16:30 ET

Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Magrath George

Dec 23, 2024 17:51 ET

Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer YERXA BENJAMIN R

Nov 25, 2024 16:23 ET

Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer Magrath George

Nov 19, 2024 16:11 ET

Opus Genetics | 4: Statement of changes in beneficial ownership of securities-Officer YERXA BENJAMIN R

Nov 12, 2024 16:41 ET

Opus Genetics | 8-K: Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update

Nov 12, 2024 09:42 ET

Opus Genetics | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 09:40 ET

D: Filing D

Nov 7, 2024 06:13 ET

4: Statement of changes in beneficial ownership of securities-Officer Magrath George

Nov 5, 2024 16:17 ET

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 4, 2024 17:10 ET